Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
Open Access
|Oct 2019Abstract
Ciprofloxacin has generally been well-tolerated and is the commonly prescribed fluoroquinolone antibiotic for treatment of urinary tract and gastrointestinal infection. The adverse effects on the liver usually range from asymptomatic elevation of liver enzymes to fulminant hepatitis. However, acute fulminant hepatitis and cholestatic hepatitis are reported rarely in literature. Here, we report a case of ciprofloxacin induced cholestatic hepatitis in a 52 year old woman following intravenous ciprofloxacin for acute gastroenteritis.
DOI: https://doi.org/10.4038/sljid.v9i2.8256 | Journal eISSN: 2448-9654
Language: English
Page range: 156 - 159
Published on: Oct 15, 2019
Published by: Sri Lankan Society for Microbiology
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 A. R. M. Misthaq, S. Pirasath, N. D. Jayaweerabandara, A. G. H. Sugathapala, published by Sri Lankan Society for Microbiology
This work is licensed under the Creative Commons License.